Foreword

por Schwartz, Peter E.
Publicado 1991

Regression of metastatic, radiation/chemotherapy-resistant uterine serous carcinoma overexpressing HER2/neu with trastuzumab emtansine (TDM-1)

por Santin, Alessandro D., Bellone, Stefania, Buza, Natalia, Schwartz, Peter E.
Publicado 2016

Clear Cell Cancer of the Uterine Corpus: The Association of Clinicopathologic Parameters and Treatment on Disease Progression

por Varughese, Joyce, Hui, Pei, Lu, Lingeng, Yu, Herbert, Schwartz, Peter E.
Publicado 2011

Correction of coagulopathy associated with non-bacterial thrombotic endocarditis (NBTE) by surgical debulking in a case of ovarian clear cell carcinoma

por Albright, Benjamin B., Black, Jonathan D., Vilardo, Nicole, Schwartz, Peter E.
Publicado 2016

Binimetinib (MEK162) in recurrent low-grade serous ovarian cancer resistant to chemotherapy and hormonal treatment

por Han, Chanhee, Bellone, Stefania, Zammataro, Luca, Schwartz, Peter E., Santin, Alessandro D.
Publicado 2018

E-cadherin and β-catenin expression in early stage cervical carcinoma: a tissue microarray study of 147 cases

por Fadare, Oluwole, Reddy, Harini, Wang, Jun, Hileeto, Denise, Schwartz, Peter E, Zheng, Wenxin
Publicado 2005

Chemotherapy for Elderly Ovarian Cancer Patients

por Muralikrishnan, Sivraj, Hatzis, Christos, Katz, Andrea, Santin, Alessandro, Schwartz, Peter E, Abu-Khalaf, Maysa M
Publicado 2016

Factors Predictive of Improved Survival in Patients With Brain Metastases From Gynecologic Cancer: A Single Institution Retrospective Study of 47 Cases and Review of the Literature

por Gressel, Gregory M., Lundsberg, Lisbet S., Altwerger, Gary, Katchi, Tasleem, Azodi, Masoud, Schwartz, Peter E., Ratner, Elena S.
Publicado 2015

Stage III uterine serous carcinoma: modern trends in multimodality treatment

por Li, Jessie Y., Young, Melissa R., Huang, Gloria, Litkouhi, Babak, Santin, Alessandro, Schwartz, Peter E., Damast, Shari
Publicado 2020

Surgical and oncologic outcomes in surgically treated women 80 years and older with endometrioid endometrial cancer as a function of their comorbidities

por AlAshqar, Abdelrahman, Ghazarian, Maddie, Webster, Emily M., Upadhyay, Animesh, Azodi, Masoud, Schwartz, Peter E., Ratner, Elena, Altwerger, Gary
Publicado 2023

Sacituzumab Govitecan (IMMU-132) in treatment-resistant uterine serous carcinoma: A case report

por Han, Chanhee, Bellone, Stefania, Schwartz, Peter E., Govindan, Serengulam V., Sharkey, Robert M., Goldenberg, David M., Santin, Alessandro D.
Publicado 2018

Safety Warning about Laparoscopic Power Morcellation in Hysterectomy: A Cost-Effectiveness Analysis of National Impact

por Xu, Xiao, Desai, Vrunda B., Schwartz, Peter E., Gross, Cary P., Lin, Haiqun, Schymura, Maria J., Wright, Jason D.
Publicado 2022

Selection of HER2/NEU negative tumor cells as a mechanism of resistance to trastuzumab in uterine serous carcinoma

por Pelligra, Silvia, Buza, Natalia, Hui, Pei, Bellone, Stefania, Zeybek, Burak, Ratner, Elena, Schwartz, Peter E., Scambia, Giovanni, Santin, Alessandro D.
Publicado 2020

High-dose-rate vaginal brachytherapy with chemotherapy for surgically staged localized uterine serous carcinoma

por Damast, Shari, Higgins, Susan A., Ratner, Elena, De Leon, Maria C., Mani, Sheida, Silasi, Dan-Arin, Azodi, Masoud, Santin, Alessandro, Rutherford, Thomas, Schwartz, Peter E.
Publicado 2015

Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy Among Patients Treated for Ovarian Cancer: A Secondary Analysis of a Randomized Clinical Trial

por Cao, Anlan, Cartmel, Brenda, Li, Fang-Yong, Gottlieb, Linda T., Harrigan, Maura, Ligibel, Jennifer A., Gogoi, Radhika, Schwartz, Peter E., Esserman, Denise A., Irwin, Melinda L., Ferrucci, Leah M.
Publicado 2023

Randomized trial of exercise on cancer‐related blood biomarkers and survival in women with ovarian cancer

por Cartmel, Brenda, Li, Fang‐yong, Zhou, Yang, Gottlieb, Linda, Lu, Lingeng, Mszar, Reed, Harrigan, Maura, Ligibel, Jennifer A., Gogoi, Radhika, Schwartz, Peter E., Risch, Harvey A., Irwin, Melinda L.
Publicado 2023

Financial toxicity in patients with gynecologic malignancies: a cross sectional study

por Zeybek, Burak, Webster, Emily, Pogosian, Natalia, Tymon-Rosario, Joan, Balch, Alan, Altwerger, Gary, Clark, Mitchell, Menderes, Gulden, Huang, Gloria, Azodi, Masoud, Ratner, Elena S., Schwartz, Peter E., Santin, Alessandro D., Andikyan, Vaagn
Publicado 2021

Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro

por Ferrari, Francesca, Bellone, Stefania, Black, Jonathan, Schwab, Carlton L., Lopez, Salvatore, Cocco, Emiliano, Bonazzoli, Elena, Predolini, Federica, Menderes, Gulden, Litkouhi, Babak, Ratner, Elena, Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter E., Santin, Alessandro D.
Publicado 2015

Expression of Tissue factor in Adenocarcinoma and Squamous Cell Carcinoma of the Uterine Cervix: Implications for immunotherapy with hI-con1, a factor VII-IgGF(c )chimeric protein...

por Cocco, Emiliano, Varughese, Joyce, Buza, Natalia, Bellone, Stefania, Glasgow, Michelle, Bellone, Marta, Todeschini, Paola, Carrara, Luisa, Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter E, Rutherford, Thomas J, Pecorelli, Sergio, Lockwood, Charles J, Santin, Alessandro D
Publicado 2011

Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer

por Albright, Benjamin B., Black, Jonathan D., Passarelli, Rachel, Gysler, Stefan, Whicker, Margaret, Altwerger, Gary, Menderes, Gulden, Buza, Natalia, Hui, Pei, Santin, Alessandro D., Azodi, Masoud, Silasi, Dan-Arin, Ratner, Elena S., Litkouhi, Babak, Schwartz, Peter E.
Publicado 2018